Crossmark

Identification of RNA binding proteins targeting TP53, RB1 and PTEN in colorectal cancer as potential biomarkers for diagnosis, drug resistance, sensitivity and prognosis

Crossref DOI link: https://doi.org/10.1007/s12672-026-05587-9

Published Online: 2026-07-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Asadi, Ava

Hashemi, Mehrdad

Peymani, Maryam

Ranji, Najmeh

Entezari, Maliheh
License Information

Text and Data Mining valid from 2026-07-13

Accepted Manuscript valid from 2026-07-13
More Information

Article History

Received: 3 September 2025

Accepted: 9 July 2026

First Online: 13 July 2026

Declarations

:

: The presented research involving human tissue samples was approved by the Biomedical Ethics Committee of the Islamic Azad University of Rasht with the Ethics Code IR.IAU.RASHT.REC.1402.022. Written informed consent was obtained from all participants prior to sample collection. All methods were performed in accordance with the relevant guidelines and regulations.

: Not applicable.

: Informed consent was obtained from all participants and/or their legal guardians prior to their inclusion in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below